Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-01-06

Clinical Trial Update: Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vaccine therapy in combination with GM-CSF for patients with acute myeloid leukemia in remission is underway. The current status of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GM-CSF (granulocyte-macrophage colony-stimulating factor)
  • Vaccine therapy

Snippet

Sponsor: The Vaccine Company | Conditions: Leukemia | Phase 3 | Status: UNKNOWN